Dallas, Texas 75247

  • Healthy

Purpose:

The main purpose of this study is to evaluate the safety and tolerability of lasmiditan in healthy Japanese and Caucasian participants. The study will also investigate how much lasmiditan gets into the bloodstream and how long it takes the body to get rid of lasmiditan when given to Japanese and Caucasians. The study will last up to 47 days for each participant.


Criteria:

Inclusion Criteria: - Are overtly healthy Japanese (first generation) or Caucasian males or females, as determined by medical history and physical examination - Have a body mass index of 18.0 to 32.0 kilograms per square meter (kg/m²), inclusive Exclusion Criteria: - Have known allergies to lasmiditan, related compounds or any components of the formulation of lasmiditan - Have previously received the investigational product in this study, withdrawn from this study, or received lasmiditan in any other study investigating lasmiditan - Have an abnormal supine blood pressure at screening. - Have a history of syncope, presyncope, uncontrolled vertigo, postural dizziness, or a risk of falls, as judged to be clinically significant by the investigator, or have orthostatic decreases in supine blood pressure of >20 millimeters of mercury (mmHg), or have orthostatic decreases in diastolic blood pressure of >10 mmHg at screening. - Are women who are pregnant, lactating, or have a positive pregnancy test at screening or admission to the clinical research unit (CRU) - Have donated blood of more than 500 milliliters (mL) within 1 month prior to screening


NCT ID:

NCT03579940


Primary Contact:

Study Director
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company


Backup Contact:

N/A


Location Contact:

Dallas, Texas 75247
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 22, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.